Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone
Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone
Active, not recruiting · NCT04392037 · Registry updated 2025-03-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2025-03-28 | NCT04392037 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amsterdam UMC, location VUmc | 102 |
| Celgene | 53 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Albert Schweitzer Ziekenhuis | Dordrecht | Netherlands | 17 |
| Amphia Ziekenhuis | Breda | Netherlands | 25 |
| Amsterdam UMC, location AMC | Amsterdam | Netherlands | 10 |
| Amsterdam UMC, location VUMC | Amsterdam | Netherlands | 9 |
| Antonius Ziekenhuis | Nieuwegein | Netherlands | 2 |
| NWZ | Alkmaar | Netherlands | 1 |
| Radboud UMC | Nijmegen | Netherlands | 25 |
| Rijnstate | Arnhem | Netherlands | 19 |
| UMC Groningen | Groningen | Netherlands | 17 |